The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03391180|
Recruitment Status : Not yet recruiting
First Posted : January 5, 2018
Last Update Posted : January 5, 2018
|Condition or disease||Intervention/treatment||Phase|
|White Spot Lesion||Drug: ICON Remineralization Drug: CPP-ACPF||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances: A Randomized Controlled Trial|
|Estimated Study Start Date :||February 2018|
|Estimated Primary Completion Date :||April 2018|
|Estimated Study Completion Date :||July 2018|
Experimental: ICON Remineralization
Firstly, Conditioning of the WSL surface by 15% HCL gel (Icon-Etch, DNG) and subsequent application of the drying solution (Icon-Dry, DMG), Numbers of additional etching intervals have been determined by visual assessment after each of the etch/dry intervals to achieve individual, customized intensities of WSL surface conditioning.
Drug: ICON Remineralization
A material used for the Remineralization of white spot lesions.
Active Comparator: CPP-ACPF
Participants in group 2 (CPP-ACPF) were treated with applying a pea sized amount of ACC-ACPF plus on a gloved finger of the examiner and rubbed the surface of the labial tooth for 4 minutes with advising the patient to avoid drinking and eating for the next 30 minutes of application.
Casein phosphopeptide-Amorphous calcium phosphate fluoride used for the remineralization of white spot lesions.
- Remineralization [ Time Frame: 3 Months ]Using DIAGNOdent Laser device.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03391180
|Contact: Omar H AlKadhi, BDS, MSemail@example.com|
|Contact: Lougin K Brekeit, BDSfirstname.lastname@example.org|
|Riyadh Colleges of Dentistry and Pharmacy|
|Riyadh, ArRiyadh, Saudi Arabia, 11681|
|Principal Investigator:||Omar H AlKadhi||Riyadh Colleges of Dentistry and Pharmacy|